Glaxosmithkline Pharmaceuticals Ltd News Today

BSE - 500660
NSE - GLAXO
ISIN - INE159A01016

Others
Glaxosmithkline Pharmaceuticals Ltd. - SEBI Circular No. SEBJ/HO/DDHS/CIR/P/2018/144 Dated November 26,2018 - Fund Raising By Issuance Of Debt Securities By Large Entities
Variety
After 30 years, Glaxo shows the right ‘PATH’ to eradicate malaria
Results
Glaxosmithkline Pharmaceuticals Ltd. - Board to consider FY19 results & Dividend on May 20, 2019
Others
Glaxosmithkline Pharmaceuticals Ltd. - Compliance Of Clause 7 (3) Of The Listing Obligations And Disclosure Requirements Regulations, 2015 (LODR) For Half Year Ended 31St March, 2019
Others
Glaxosmithkline Pharmaceuticals Ltd. - Shareholding for the Period Ended March 31, 2019
Others
Glaxosmithkline Pharmaceuticals Ltd. - Closure of Trading Window
Others
Glaxosmithkline Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Change in Directorate
Others
Glaxosmithkline Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Others
Glaxosmithkline Pharmaceuticals Ltd. - Loss of Share Certificate / Issue of Duplicate Share Certificate
Companies
Bharat Biotech buys Chiron Behring Vaccines from GSK
While Bharat Biotech now has a capacity to make 10 million doses, Chiron has 15 million capacity for rabies vaccine
Others
Glaxosmithkline Pharmaceuticals Ltd. - Loss of Share Certificate / Issue of Duplicate Share Certificate
Others
Glaxosmithkline Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Sign into Unlock benefits!

Access 10 free stories per month
Access to comment on every story
Sign up/Manage to our newsletters
Get notified by email for early preview to new features, discounts & offers